Unbiased HIV Patent Pool — A Free-Market, Middle-Income Countries Open Model
Brand name pharmaceutical companies’ concerns about profit losses related to the UNITAID patent pool might undermine access to newer and appropriate HIV medicine formulations in resource-limited settings. A universally agreed strategy to supplement UNITAID plan is therefore needed, writes Daniele Dionisio.

The Intellectual Property Watch Monthly Edition features top news on international IP policymaking, the latest on who is coming and going in the international IP community, news briefs and more. The March/April edition is now available for subscribers at: http://www.ip-watch.org/user/newsletter.